tradingkey.logo


iRhythm Technologies Inc

IRTC
188.300USD
+5.090+2.78%
āļ›āļīāļ” 11/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
6.06BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
āļ‚āļēāļ”āļ—āļļāļ™P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ iRhythm Technologies Inc āļšāļĢāļīāļĐāļąāļ—

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

āļ‚āđ‰āļ­āļĄāļđāļĨ iRhythm Technologies Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™IRTC
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—iRhythm Technologies Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 20, 2016
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Quentin S. Blackford
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™2000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Oct 20
āļ—āļĩāđˆāļ­āļĒāļđāđˆ699 8th Street
āđ€āļĄāļ·āļ­āļ‡SAN FRANCISCO
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ Global Select Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ94103
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ14156325700
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.irhythmtech.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™IRTC
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 20, 2016
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Quentin S. Blackford

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ iRhythm Technologies Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+14.39%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
7.73K
+21.32%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
3.96K
-66.88%
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
2.04K
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 18 āļž.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 18 āļž.āļĒ.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
āļ­āļ·āđˆāļ™ āđ†
64.04%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
āļ­āļ·āđˆāļ™ āđ†
64.04%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
66.24%
Investment Advisor/Hedge Fund
28.39%
Hedge Fund
10.19%
Research Firm
5.20%
Family Office
1.35%
Individual Investor
1.02%
Pension Fund
0.97%
Sovereign Wealth Fund
0.71%
Bank and Trust
0.54%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 1 āļ•.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 1 āļ•.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q3
609
36.08M
112.00%
-5.27M
2025Q2
586
36.46M
113.50%
-2.59M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
2023Q2
537
34.27M
112.49%
-3.29M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
3.23M
10.05%
+127.22K
+4.10%
Jun 30, 2025
Artisan Partners Limited Partnership
2.74M
8.53%
-73.44K
-2.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.33M
7.25%
-18.29K
-0.78%
Jun 30, 2025
Sands Capital Management, LLC
2.92M
9.07%
-100.68K
-3.34%
Jun 30, 2025
Capital Research Global Investors
1.51M
4.69%
-695.76K
-31.59%
Jun 30, 2025
Capital World Investors
1.44M
4.47%
+247.00
+0.02%
Aug 31, 2025
State Street Investment Management (US)
868.52K
2.7%
-49.16K
-5.36%
Jun 30, 2025
Geode Capital Management, L.L.C.
767.34K
2.39%
+16.97K
+2.26%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
739.33K
2.3%
-50.67K
-6.41%
Jun 30, 2025
Eventide Asset Management, LLC
691.57K
2.15%
-48.49K
-6.55%
Jun 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 2 āļž.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 2 āļž.āļĒ.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Global X HealthTech ETF
4.9%
Fidelity Digital Health ETF
2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.56%
SPDR S&P Health Care Equipment ETF
1.55%
Langar Global HealthTech ETF
1.52%
Goldman Sachs Future Health Care Equity ETF
1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
1.13%
Inspire Fidelis Multi Factor ETF
1.03%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Global X HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™4.9%
Fidelity Digital Health ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.72%
ROBO Global Healthcare Technology & Innovation ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.56%
SPDR S&P Health Care Equipment ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.55%
Langar Global HealthTech ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.52%
Goldman Sachs Future Health Care Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.13%
Inspire Fidelis Multi Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.03%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āđƒāļ„āļĢāļ„āļ·āļ­āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ iRhythm Technologies Inc?


āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ iRhythm Technologies Inc āđ„āļ”āđ‰āđāļāđˆ:
The Vanguard Group, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 3.23M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 10.05% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Artisan Partners Limited Partnership āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 2.74M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 8.53% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
BlackRock Institutional Trust Company, N.A. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 2.33M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 7.25% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Sands Capital Management, LLC āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 2.92M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 9.07% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Capital Research Global Investors āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 1.51M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 4.69% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”

āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ iRhythm Technologies Inc āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ iRhythm Technologies Inc āđ„āļ”āđ‰āđāļāđˆ
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.

āļĄāļĩāļāļĩāđˆāļŠāļ–āļēāļšāļąāļ™āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ iRhythm Technologies Inc (IRTC)?


āļ“ āļ§āļąāļ™āļ—āļĩāđˆ 2025Q3 āļĄāļĩāļŠāļ–āļēāļšāļąāļ™āļˆāļģāļ™āļ§āļ™ 609 āđāļŦāđˆāļ‡āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ iRhythm Technologies Inc āđ‚āļ”āļĒāļĄāļĩāļĄāļđāļĨāļ„āđˆāļēāļĢāļ§āļĄāļ›āļĢāļ°āļĄāļēāļ“ 36.08M āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 112.00% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ” āđ€āļĄāļ·āđˆāļ­āđ€āļ—āļĩāļĒāļšāļāļąāļšāļ§āļąāļ™āļ—āļĩāđˆ 2025Q2 āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™āđ„āļ”āđ‰āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™ -1.50%

āđāļŦāļĨāđˆāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŦāļĨāļąāļāļ‚āļ­āļ‡ iRhythm Technologies Inc āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āđ€āļĄāļ·āđˆāļ­āļ§āļąāļ™āļ—āļĩāđˆ FY2025Q2 āļ˜āļļāļĢāļāļīāļˆāļ”āđ‰āļēāļ™ Commercial Payors āļŠāļĢāđ‰āļēāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāđ‰āļāļąāļš iRhythm Technologies Inc āļ„āļīāļ”āđ€āļ›āđ‡āļ™āļĄāļđāļĨāļ„āđˆāļē 97.72M āđāļĨāļ°āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 52.34% āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļĢāļ§āļĄ
KeyAI
î™